about
Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabul...
Read More
2.78
-0.03
(-1.07%)
164.7K
XNAS Volume
XNAS 10 Jul, 2026 4:00 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Veru Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..